OmniActive Health Technologies appoints Amit Chopra as its new president and CEO
OmniActive explains in a press release that Chopra has a wealth of experience in general management, commercial, manufacturing, mergers & acquisitions, and innovation, most recently serving as managing director for India and South Asia at Thermo Fisher Scientific.
Amit Chopra. Image courtesy of OmniActive Health Technologies
OmniActive Health Technologies (Bridgewater, NJ and Mumbai, India) has announced the appointment of Amit Chopra as the company’s new president and chief executive officer. OmniActive explains in a press release that Chopra has a wealth of experience in general management, commercial, manufacturing, mergers & acquisitions, and innovation, most recently serving as managing director for India and South Asia at Thermo Fisher Scientific. Prior to this, he held a number of leadership positions with ICI in India and Asia Pacific. Chopra holds a bachelor’s degree in chemistry from St. Stephen’s College, University of Delhi, and an MBA in marketing and finance from XLRI Jamshedpur, India.
“OmniActive has continued to experience tremendous growth in recent years, and as we examined our ambitious goals, it was clear that we needed a leader to drive expansion in key global regions while overseeing our operations in India,” said Sanjay Mariwala, founder and executive chairman of OmniActive, in a press release. “I am confident that Amit’s strategic thinking, business acumen, and successful record of execution will be invaluable in shaping the Company’s future.”
“OmniActive is a pioneer and an innovator, and the company’s investments in research and sustainability have led to meaningful breakthroughs in the global healthcare and nutraceuticals industries,” said Chopra. “OmniActive’s inspiring mission of ‘improving lives through innovative science and natural health solutions’ aligns closely with my values. I am thrilled to join OmniActive as president and CEO and look forward to working with OmniActive’s talented team to accelerate business growth."
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
